As per the independent prognostic and survival analyses, few of the important differentially expressed genes, including MRC1, CP, ITGA5, SNCA, HARS1, ENPP1, and PLAU may function as potent biomarkers for screening and characterizing different stages of CHOL patients with COVID-19. The gene discussed is SNCA; the disease is COVID-19.